Late Stage Cancer

https://www.pharmexec.com/view/fda-approves-tevimbra-beigene-s-treatment-for-adults-with-unresectable-or-metastatic-esophageal-squamous-carcinoma

https://www.onclive.com/view/dr-shah-on-responses-with-pembrolizumab-plus-chemo-by-pd-1-status-in-esophageal-cancer

https://www.sciencedirect.com/science/article/abs/pii/S0003497524001255

https://www.docwirenews.com/post/keynote-590-long-term-outcomes-of-first-line-pembrolizumab-chemotherapy-for-advanced-esophageal-cancer

https://www.targetedonc.com/view/nivolumab-plus-chemotherapy-demonstrates-superior-os-in-esophageal-gastric-cancer

https://www.onclive.com/view/shitara-and-xu-discuss-potential-fda-approval-of-zolbetuximab-in-cldn18-2-gastric-gej-adenocarcinoma?utm_source=www.onclive.com&utm_medium=relatedContent

https://finance.yahoo.com/news/cstone-announces-nmpa-approval-sugemalimab-041000120.html

https://www.targetedonc.com/view/domvanalimab-regimen-shows-potential-in-first-line-gi-cancer-treatment